ASHLEY WHITLEY: Open Payments
NPI 1295973147 · GRAYSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 16 payments from 10 companies in 2025. Trend: 2023 $741 · 2024 $659 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Novo Nordisk Inc | 3 | $53 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Lilly USA, LLC | 2 | $30 |
| EVOKE PHARMA, INC. | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Corcept Therapeutics | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: CAPLYTA, TRELEGY ELLIPTA, MOUNJARO, Rybelsus, GIMOTI, UBRELVY, NURTEC ODT, XIFAXAN.
Industry payments across KY — which companies pay providers there.
